12 results
8-K
EX-1.1
ABOS
Acumen Pharmaceuticals Inc
20 Jul 23
Entry into a Material Definitive Agreement
4:06pm
with, and since May 25, 2018, has been and currently is in compliance with, the European Union General Data Protection Regulation (“GDPR”) (EU 2016
S-3
EX-1.2
ABOS
Acumen Pharmaceuticals Inc
1 Jul 22
Shelf registration
5:06pm
is in compliance with, the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679); and the Company has taken or will take commercially reasonable
10-K
2021 FY
ABOS
Acumen Pharmaceuticals Inc
28 Mar 22
Annual report
4:51pm
identifiable health information in a manner that is not authorized or permitted by HIPAA.
In Europe, the General Data Protection Regulation, or GDPR, took
10-Q
foi8u9w59k9l
16 Aug 21
Quarterly report
4:51pm
424B4
gbm7jk6ywjg3jzr6
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
EX-1.1
dqp1yai uxlcf5
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
qlllt74ae81cc7w
24 Jun 21
IPO registration (amended)
8:17am
S-1
n0btkt21
9 Jun 21
IPO registration
5:02pm
DRS/A
mf66f8dtvrtymdq
14 May 21
Draft registration statement (amended)
12:00am
DRS
31kgopijhlc62k79 fwy
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next